Literature DB >> 22721757

[Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003].

P Giraud1, J Djadi-Prat, E Morvan, M Morelle, R Remmonay, N Pourel, C Durdux, C Carrie, F Mornex, C Le Péchoux, J-M Bachaud, P Boisselier, V Beckendorf, R Dendale, C Daveau, R Garcia.   

Abstract

PURPOSE: To compare respiratory-gated conformal radiotherapy versus conventional conformal radiotherapy for the irradiation of non-small cells lung cancer and breast cancer. PATIENTS AND METHODS: The STIC 2003 project was a comparative, non-randomized, multicenter and prospective study that included in 20 French centers between April 2004 and June 2008, 634 evaluable patients, 401 non-small cells lung cancer and 233 breast cancers.
RESULTS: The final results confirmed the feasibility and good reproducibility of the various respiratory-gated conformal radiotherapy systems regardless of tumour location. The results of this study demonstrated a marked reduction of dosimetric parameters predictive of pulmonary, cardiac and esophageal toxicity, especially for non-small cells lung cancer, as a result of the various respiratory gating techniques. These dosimetric benefits were mainly observed with deep inspiration breath-hold techniques (ABC and SDX), which markedly increased the total lung volume compared to the inspiration-synchronized system based on tidal volume (RPM). For non-small cells lung cancer, these theoretical dosimetric benefits were correlated with a significant reduction in clinically acute and late toxicities, especially the pulmonary. For breast cancer, although less clear due to the lower total dose, there was a decrease in the dose delivered to the heart, potentially reducing the risk of cardiac toxicity in the long-term, especially during the irradiation of the left breast, and a reduction in dose to the contra lateral breast.
CONCLUSION: Respiratory-gated radiotherapy appears to be essential to reduce the risk of acute and late toxicities, especially for lungs and heart, during irradiation of non-small cells lung cancer and breast cancers.
Copyright © 2012 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22721757     DOI: 10.1016/j.canrad.2012.03.005

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

Review 1.  Post-operative radiation therapy.

Authors:  Amaury Paumier; Cécile Le Péchoux
Journal:  Transl Lung Cancer Res       Date:  2013-10

2.  Clinical experience using a video-guided spirometry system for deep inhalation breath-hold radiotherapy of left-sided breast cancer.

Authors:  Wensha Yang; Elizabeth M McKenzie; Michele Burnison; Stephen Shiao; Amin Mirhadi; Behrooz Hakimian; Robert Reznik; Richard Tuli; Howard Sandler; Benedick A Fraass
Journal:  J Appl Clin Med Phys       Date:  2015-03-08       Impact factor: 2.102

3.  Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy.

Authors:  Qiwei Yao; Rong Zheng; Guozhu Xie; Guixiang Liao; Shasha Du; Chen Ren; Rong Li; Xiaoshan Lin; Daokun Hu; Yawei Yuan
Journal:  Sci Rep       Date:  2015-03-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.